Poster Abstract Session:
135. Clinical Infectious Diseases: Bacteremia and Endocarditis
Friday, October 28, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Adult ID

Presentations:
Simple scoring system using red cell distribution, delta neutrophil index, and platelet count for prediction of mortality in patients with severe sepsis or septic shock
Yong Chan Kim, MD ; Moo Hyun Kim, MD ; Woo Yong Jeong, MD ; Dong Hyun Oh, MD ; Eun Jin Kim, MD ; Je Eun Song, MD ; In Young Jung, MD ; Su Jin Jeong, MD/PhD ; Jun Yong Choi, MD, PhD ; Young Goo Song, MD, PhD ; June Myung Kim, MD, PhD ; Nam Su Ku, MD
Trends in Sepsis Incidence and Outcome: Potential Implications of Mismatch between Administrative versus True Incidence
Tuyet-Trinh Truong, MD ; Jashvant Poeran, MD, PhD ; Ken Mccardle, MS ; Shirish Huprikar, MD ; Madhu Mazumdar, PhD ; Allison Glasser, BSPT, MBA ; Scott Lorin, MD MBA ; Vicki Lopachin, MD, MBA
Posters
  • IDWeek Sepsis Incidence.pdf (1.5 MB)
  • The Influence of Patient and Organizational Factors on a Hospital-Wide Sepsis Screening Tool
    Peter Shearer, MD ; Jashvant Poeran, MD, PhD ; Ken Mccardle, MS ; Madhu Mazumdar, PhD ; Gopi Patel, MD ; Vicki Lopachin, MD, MBA ; Allison Glasser, BSPT, MBA ; Scott Lorin, MD MBA
    Posters
  • poster 1.pdf (574.5 kB)
  • Comparative-Effectiveness of Ceftaroline and Daptomycin as First-line Therapy for Patients with Bacteremia or Sepsis Admitted to Hospitals in the United States Veterans Health Care System
    Marilyn L. Mootz, BS, PharmD Student ; Rachel S. Britt, PharmD Student ; Grace C. Lee, PharmD, PhD ; Kelly R. Reveles, PharmD, PhD ; Natalie K. Boyd, PharmD, MS ; Kirk E. Evoy, PharmD ; Christopher R. Frei, PharmD, MSc
    Hospital-level Variability in Mortality during Hospitalizations with ICD-9 Codes for Severe Sepsis/Septic Shock, United States, 2013.
    Kelly Mccormick, MSPH ; James Baggs, PhD ; Raymund Dantes, MD, MPH ; Anthony Fiore, MD, FIDSA ; John Jernigan, MD, MS ; Shelley S. Magill, MD, PhD ; Lauren Epstein, MD, MSc
    Cutoff Value Of Serum Lactate Level At Diagnosis Of Septic Shock; Question About Its Validity.
    Dong Hyun Oh, MD ; Moo Hyun Kim, MD ; Woo Yong Jeong, MD ; Yong Chan Kim, MD ; Eun Jin Kim, MD ; Je Eun Song, MD ; In Young Jung, MD ; Nam Su Ku, MD ; Jun Yong Choi, MD, PhD ; Young Goo Song, MD, PhD ; June Myung Kim, MD, PhD ; Su Jin Jeong, MD/PhD
    Improvement in the Diagnosis of Patients With Central Line Related Bloodstream Infections by Proper Blood Culture Drawing and Labeling in an Emergency Center
    Anne-Marie Chaftari, MD ; Patrick Chaftari, MD ; Javier Adachi, MD, FIDSA ; Ray Hachem, MD, FIDSA ; Sammy Raad, MS ; Elizabeth Natividad, BSN ; Nora Oliver, MD, MPH ; Bena Elickalputhenpura, BA ; Jeffrey Tarrand, MD ; Issam Raad, MD, FIDSA, FSHEA
    Decreased Risk of Septicemia or Bacteremia among New End-stage Renal Disease Patients Receiving Hemodialysis with Early Fistula Placement
    Sophia Kazakova, MD, MPH, PhD ; Sarah Yi, PhD ; Priti Patel, MD, MPH ; Duc Nguyen, PhD ; Ibironke Apata, MD ; John Jernigan, MD, MS
    Impact of Multiplex Polymerase Chain Reaction (PCR) Testing and Automatic Infectious Disease Consultation in Patients with Gram-Negative Bacteremia
    Ann R. Cowden, PharmD ; Patrick D. Ratliff, PharmD ; G. Shawn King, PharmD ; Karen E. Luh, PhD ; Dana M. Stephens, MT, CIC ; Charles Kennedy, MD ; William R. Judd, PharmD
    Clinical Outcomes and Costs of Multi-Drug Resistant Gram Negative Bacterial Bloodstream Infections: Initial Results from a 12-year Prospective Cohort Study
    Joshua T. Thaden, MD, PhD ; Yanhong Li, PhD ; Felicia Ruffin, RN, MSN ; Shelby Reed, PhD ; Vance G Fowler Jr, MD, MHS
    Impact of Empiric Carbapenem Beta-Lactam (CBL) versus Non-Carbapenem Beta-Lactam (N-CBL) Treatment on Mortality and Microbiological Response Rates for Third-Generation Cephalosporin-Resistant (3GCR) Enterobacteriaceae Bloodstream Infections (BSI)
    Melissa Kirejczyk, BS ; Srijana Jonchhe, PharmD ; Stephanie E. Giancola, PharmD ; Michael Hogan, PharmD ; Sunwoo Ahn, PharmD ; Monica V. Mahoney, PharmD, BCPS-AQ ID ; Graham M. Snyder, MD, SM ; Kirthana R. Beaulac, PharmD ; Elizabeth B. Hirsch, PharmD, BCPS
    Association between body mass index and mortality in gram-negative bloodstream infections
    P. Brandon Bookstaver, PharmD, FCCP, BCPS, AAHIVP ; Julie Ann Justo, PharmD, MS, BCPS-AQ ID ; Joseph Kohn, PharmD, BCPS ; Casey Troficanto, PharmD, BCPS ; Zhengguan Yang, PharmD Candidate ; Jacob Lines, PharmD Candidate ; Helmut Albrecht, MD ; Majdi Al-Hasan, MBBS
    Empirical Treatment of Enterobacteriaceae Bacteremia in Febrile Neutropenic Patient: Carbapenem May Not Improve Survival Compared with Combination of Cefepime with Isepamicin
    Jae-Ki Choi, M.D. ; Dong-Gun Lee, M.D., Ph.D. ; Sung-Yeon Cho, M.D. ; Si-Hyun Kim, M.D., Ph.D. ; Hyo Jin Lee, M.D. ; Su-Mi Choi, M.D., Ph.D ; Sun Hee Park, M.D., Ph.D. ; Jung-Hyun Choi, M.D., Ph.D. ; Jin-Hong Yoo, M.D., Ph.D.
    Clinical Utility of Cefepime for the Management of Bacteremia Secondary to AmpC Producing Organisms
    Lacie Mckamey, PharmD ; Kenneth Klinker, PharmD ; Samuel Borgert, PharmD ; Nicole Iovine, MD, PhD ; Kartikeya Cherabuddi, MD
    Comparison of Bacterial and Clinical Features of Klebsiella pneumoniae and Klebsiella oxytoca Bloodstream Infections: Experience at a Tertiary Hospital in Japan
    Akihiko Shimizu, MD ; Naoto Hosokawa, M.D. ; Yoshihito Otsuka, Ph.D. ; Ryota Hase, MD ; Daisuke Suzuki, MD ; Kazuyasu Miyoshi, MD ; Koji Fujita, MD ; Hiroyuki Suzuki, MD ; Akihiro Anma, MD ; Hirokazu Kuroda, MD ; Satoshi Hayano, MD
    Emergence of carbapenem resistant hypervirulent K.pneumoniae – a global threat?
    Chaitra Shankar, MSc ; Laura Nabarro, MD ; Raji Ravi, BSc ; Shalini Anandan, MD ; Veeraraghavan Balaji, MD
    Posters
  • IDWeek poster.pdf (689.3 kB)
  • Optimal Duration of Antimicrobial Therapy for Bloodstream Infections due to Gram-Negative Bacilli
    Avery Nelson, BS ; Julie Ann Justo, PharmD, MS, BCPS-AQ ID ; P. Brandon Bookstaver, PharmD, FCCP, BCPS, AAHIVP ; Joseph Kohn, PharmD, BCPS ; Helmut Albrecht, MD ; Majdi Al-Hasan, MBBS
    Staphylococcus aureus bacteremia: the impact of infectious diseases consultation at a large urban hospital
    Charles Kyriakos Vorkas, MD ; Shashi Kapadia, MD ; Thomas Baker, MD ; Kristen M. Marks, MD ; Ole Vielemeyer, MD
    Posters
  • Slide1.png (192.9 kB)
  • Vancomycin Serum Trough Levels and Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia
    Tooba Rehman, MD ; Vanthida Huang, PharmD ; Yuan Xin, MPH ; Khulood Rizvi, MD ; Ayesha Niazy, MD ; Ana C. Bardossy, MD ; Marcus Zervos, MD
    Posters
  • Poster PDF.pdf (517.1 kB)
  • Characterization of Recurrent Methicillin-resistant Staphylococcus aureus Bloodstream Infections
    Ayesha Niazy, MD ; Ana C. Bardossy, MD ; Khulood Rizvi, MD ; Tooba Rehman, MD ; Pamela Hartman, B.S. ; Daniela Moreno, MPH ; Mary Beth Perri, MT ; Marcus Zervos, MD
    BAC DOOR: A Clinician Ranking Exercise for Better S. aureus Bacteremia Trial Design
    Sarah Doernberg, MD ; Natalia Gouskova, PhD ; Scott Evans, PhD, MS ; Helen Boucher, MD, FIDSA ; G Corey, MD ; Sara Cosgrove, MD, MS, FIDSA, FSHEA ; Henry Chambers, MD, FIDSA ; Vance Fowler, MD ; Thomas Holland, MD, MSc-GH
    Phenotypic and Genotypic Characterization of Staphylococcus aureus Bloodstream Isolates in a Single Large Medical Center in Southeastern Minnesota
    Kyung-Hwa Park, MD ; Kerryl Greenwood-Quaintance, MS ; Suzannah Schmidt, MS ; James Uhl, MS ; Scott Cunningham, MT(ASCP), MS ; Govindarajan Rajagopalan, Ph.D. ; Robin Patel, MD, FIDSA, D(ABMM)
    Combination Therapy Did Not Reduce 30-day Treatment Failure in Patients With Staphylococcus aureus Bacteremia (SAB)
    Natasha Holmes, MBBS FRACP PhD ; J Owen Robinson, MD FRACP ; Sebastian Van Hal, MBBS FRACP FRCPA PhD ; Wendy Munckhof, MBBS FRACP FRCPA PhD ; Eugene Athan, MBBS, FRACP, MPH ; Tony Korman, MBBS FRACP FRCPA ; Allen C. Cheng, MBBS, FRACP, MPH, PhD ; Matthew O'sullivan, MBBS MMed FRACP FRCPA PhD ; Tara Anderson, MBBS FRACP ; Sally a. Roberts, MBChB, FRACP, FRCPA ; Sanchia Warren, MBBS FRACP ; John Turnidge, MBBS FRACP FRCPA ; Benjamin Howden, MBBS FRACP FRCPA PhD ; Paul Johnson, MBBS FRACP PhD
    Outcomes in Patients Treated with a Beta-Lactam for Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia Stratified by Vancomycin Minimum Inhibitory Concentration (MIC)
    Kristen Landry, MD ; Robert Leininger, MD ; Jessica Johnston, MS ; Kurt Stevenson, MD, MPH, FSHEA ; Erica Reed, PharmD, BCPS-AQ ID
    Treatment Outcomes with Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections
    Corey C. Burrelli, PharmD ; Graham M. Snyder, MD, SM ; Howard S. Gold, MD, FIDSA ; Christopher McCoy, PharmD, BCPS-AQ ID ; Monica V. Mahoney, PharmD, BCPS-AQ ID ; Elizabeth B. Hirsch, PharmD, BCPS
    Posters
  • NAF CFZ MSSA BSI Poster.pdf (538.5 kB)
  • Outcomes of Methicillin Susceptible Staphylococcus aureus Blood Stream Infections with Various Beta-Lactam Therapy
    Ashley Gale, PharmD ; Milena M. Mclaughlin, PharmD, MSc ; Viktorija O. Barr, PharmD ; Hankyung Cho, PharmD Candidate ; Michael Postelnick, BS Pharm ; Elise M. Gilbert, PharmD
    Outcomes and Tolerability of Nafcillin versus Cefazolin for Systemic Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections
    Wesley Hoffmann, Pharm.D. ; Cinda Christensen, Pharm.D., BCPS-AQ ID ; Stuart H. Cohen, MD, FIDSA, FSHEA, FACP
    Comparative effectiveness and efficacy of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus Bacteremia: A prospective multi-center cohort study in Korea
    Shinwon Lee, MD ; Kyoung-Ho Song, MD ; Sook-in Jung, MD ; Yeon-Sook Kim, MD ; Sungmin Kiem, MD ; Young Keun Kim, MD ; Yee Gyung Kwak, MD ; Hee-Chang Jang, MD ; Kyung-Hwa Park, MD ; Chung-Jong Kim, MD ; Hye-in Kim, MD ; Jeong Eun Lee, MD ; Nam Joong Kim, MD, PhD ; Myoung-Don Oh, MD, PhD ; Hong Bin Kim, MD, PhD
    Ceftriaxone for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections
    Katie E. Barber, PharmD ; Jamie L. Wagner, PharmD ; Rachel Lowe, PharmD Candidate ; Kayla R. Stover, PharmD, BCPS
    Evaluation of Optimal Treatment Strategy of Skin and Soft Tissue Infections with Uncomplicated Methicillin-Resistant Staphylococcal Aureus Bacteremia
    Khulood Rizvi, MD ; Ayesha Niazy, MD ; Tooba Rehman, MD ; Ana C. Bardossy, MD ; Marcus Zervos, MD
    Posters
  • IDSA poster.pdf (486.3 kB)
  • Outcomes among Patients with Staphylococcus aureus Bacteremia in the Veterans Affairs Healthcare System
    Ellyn Ercolano, MS ; Sara Gale, PhD, MPH ; Nicholas Lewin-Koh, MS ; Yinong Young-Xu, ScD, MS, MA ; Melicent Peck, MD, PhD
    Posters
  • IDWeekPoster_FINAL_2 (1).pdf (399.5 kB)
  • Epidemiology of Staphylococcus aureus Bacteremia in a Large tertiary center
    Vishnu Kommineni, MD ; Karen Hansen-Rojas, MPH, BSN, RN ; Farrah Ibrahim, MD ; Ali Hassoun, MD FIDSA FACP
    Impact of Vancomycin Minimum Inhibitory Concentration on Clinical Outcome of Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Shi Nae Yu, MD ; Yong Pil Chong, MD ; Su-Jin Park, PhD ; Sung-Han Kim, MD ; Sang-Oh Lee, MD ; Sang-Ho Choi, MD ; Jun Hee Woo, MD ; Yang Soo Kim, MD
    Clinical Outcomes of Staphylococcus aureus Bacteremia Following Introduction of Mandatory Infectious Disease Specialist Consultation: A Retrospective 12-Month Study
    Venus Valbuena, BScN, RN ; Anthony Bai, BHSc, MD ; Mahbuba Meem, BSc, MSc ; Adrienne Showler, MD ; Marilyn Steinberg, RN ; Chaim Bell, MD, PhD ; Andrew Morris, MD, SM
    Impact of an Infectious Diseases Consult on Staphylococcus aureus Bacteremia Management
    John Edelstein, PharmD ; Jessica Pakulski, PharmD, BCPS ; Lindsey Eitniear, PharmD ; William Helmink, MBA, MT (ASCP) ; Claudiu Georgescu, MD ; Kelli Cole, PharmD, BCPS
    agr Dysfunction as an Independent Risk Factor for In-hospital Mortality in Persistent Methicillin-resistant Staphylococcus aureus Bacteremia
    Chang Kyung Kang, MD ; Sook-in Jung, MD ; Chung-Jong Kim, MD ; Kyoung-Ho Song, MD ; Eu Suk Kim, MD ; Seung Ji Kang, MD ; Nak-Hyun Kim, MD ; Wan Beom Park, MD ; Young Keun Kim, MD ; Hee-Chang Jang, MD ; Shinwon Lee, MD ; Yeon-Sook Kim, MD ; Yee Gyung Kwak, MD ; Ki Tae Kwon, MD ; Sungmin Kiem, MD ; Hong Bin Kim, MD, PhD
    Prediction Model to Identify Patients at Risk of 30-day Treatment Failure in Patients with Staphylococcus aureus Bacteremia
    Natasha Holmes, MBBS FRACP PhD ; J Owen Robinson, MD FRACP ; Sebastian Van Hal, MBBS FRACP FRCPA PhD ; Wendy Munckhof, MBBS FRACP FRCPA PhD ; Eugene Athan, MBBS, FRACP, MPH ; Tony Korman, MBBS FRACP FRCPA ; Allen C. Cheng, MBBS, FRACP, MPH, PhD ; Matthew O'sullivan, MBBS MMed FRACP FRCPA PhD ; Tara Anderson, MBBS FRACP ; Sally a. Roberts, MBChB, FRACP, FRCPA ; Sanchia Warren, MBBS FRACP ; John Turnidge, MBBS FRACP FRCPA ; Paul Johnson, MBBS FRACP PhD ; Benjamin Howden, MBBS FRACP FRCPA PhD
    Clinical Use of Ceftaroline Fosamil for the Treatment of Gram-Positive Bacteremia: CAPTURE Study Experience
    Christy Maggiore, PharmD, BCPS ; Leonard B. Johnson, MD, FIDSA ; Keith Kaye, MD ; Chad M. Cannon, MD ; Jose Vazquez, MD, FACP, FIDSA
    Clinical characteristics of primary pneumococcal bacteremia in adult patients in the Republic of Korea
    Jong Hun Kim, MD ; Seung Hee Baik, MD ; Joon Young Song, MD ; Won Suk Choi, M.D. ; Sae Yoon Kee, MD ; Younghee Jung, MD ; In Kyu Bae, MD ; Hyun Hee Kwon, MD, Ph.D ; Jeong Yeon Kim, M.D., Ph.D. ; Young Hwa Choi, MD ; Young Keun Kim, MD ; Ji an Hur, MD ; Ki-Eun Hwang, MD ; Yu-Mi Lee, MD ; Ji Hyun Yoon, MD ; Dong-Min Kim, M.D., PhD. ; Yoon Jung Oh, MD ; Jin-Won Chung, MD ; Yeon-Sook Kim, MD ; Hye Won Jeong, M.D. Ph.D. ; Jacob Lee, M.D. ; Byung Chul Chun, M.D., Ph.D. ; Min-Ja Kim, MD
    Bacteremia: Changing Microbiology Over Six Years
    Riad Khatib, MD ; Leonard B. Johnson, MD, FIDSA ; Mohamad Fakih, MD, MPH, FIDSA ; Kathleen Riederer, BS, MT ; Laurence Briski, MD ; Vladimir Labalo, MD
    Posters
  • Slide1.GIF (710.4 kB)
  • Evaluating the Relationship and Appropriateness of Treatment of Obese Patients with Group B Streptococcus Bloodstream Infections
    Sheena Bharti, DO ; Thien-Ly Doan, PharmD ; Barbara Edwards, MD ; Rebecca Schwartz, PhD ; Lawrence Ha, MD
    Posters
  • GBS poster revised 9 23 16.pdf (116.1 kB)
  • Leclercia Adecarboxylata Bacteremia: A Case Report and Literature Review of Cases
    Akika Ando, MD ; Lorrance Majewski, DO ; Eric Kajioka, MD
    Erysipelothrix rhusiopathiae bloodstream infection – A 22-Year Experience at Mayo Clinic, Minnesota
    Jasmine R. Marcelin, MD ; Eugene M. Tan, MD ; Naima Adeel, MB BCh ; Roshan Lewis, MD ; Mark Enzler, MD ; Pritish K. Tosh, MD
    Posters
  • Poster.jpg (301.8 kB)
  • 14-Year Survey in a Swedish County Reveals an Alarming Increase in Bloodstream Infections (BSI). Comorbidity - an Independent Risk Factor for Both BSI and Mortality
    Martin Holmbom, MD ; Christian Giske, MD, Associate Professor ; Lennart E Nilsson, Professor, PhD ; Mikael Hoffmann, MD, PhD ; Mats Fredriksson, PhD, Associate Professor ; Carina Claesson, PhD ; Åse Östholm-Balkhed, MD, PhD ; Hakan Hanberger, Professor, MD
    Predictive Factors associated with Stenotrophomonas maltophilia bacteremia infected by Antibiotic-resistant strains
    Eun Jin Kim, MD ; Moo Hyun Kim, MD ; Woo Yong Jeong, MD ; In Young Jung, MD ; Yong Chan Kim, MD ; Dong Hyun Oh, MD ; Je Eun Song, MD ; Nam Su Ku, MD ; Jun Yong Choi, MD, PhD ; Young Goo Song, MD, PhD ; June Myung Kim, MD, PhD ; Su Jin Jeong, MD/PhD
    The Effect of Rapid Molecular Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A systematic review and meta-analysis
    Tristan Timbrook, Pharm.D., MBA, BCPS ; Jacob Morton, PharmD, MBA, BCPS ; Aisling Caffrey, PhD, MS ; Kerry Laplante, Pharm.D., FCCP
    Who needs echocardiography for the diagnosis of infective endocarditis among non-pneumococcal streptococcal bacteremia patients?
    Sang Ah Lee, MD ; Min Jung Kim, MD ; Shin-Woo Kim, MD, PhD ; Sook-in Jung, MD ; Seong Eun Kim, MD ; Uh Jin Kim, MD ; Hyun-Ha Chang, MD
    Echo-Negative Endocarditis: Analysis of 538 Consecutive Transesophageal Echocardiographies.
    Mirit Hershman-Sarafov, MD ; Alona Paz, MD ; Israel Potasman, MD, FIDSA
    Native Valve Endocarditis in a Dialysis Patient by Achromobacter xylosoxidans, rare pathogen
    Shweta Kumar, MD ; Jagroop Khaira, MD ; Damodar Penigalapati, MD
    Impact of a Primary Inpatient Electrophysiology Service on Cardiovascular Implantable Electronic Device Infections in a Tertiary Care Hospital
    Eugene M. Tan, MD ; Avish Nagpal, MD ; Daniel C. Desimone, MD ; Brenda Anderson, RN ; Jane Linderbaum, APRN, CNP ; Thomas De Ziel, RN ; Zhuo Li, MS ; Muhammad R. Sohail, MD, FIDSA ; Yong-Mei Cha, M.D. ; Erica Loomis, MD ; Raul Espinosa, MD ; Paul a. Friedman, MD ; Kevin Greason, MD ; Henry Schiller, MD ; Abinash Virk, MD, FIDSA ; Walter R. Wilson, MD, FIDSA ; James M. Steckelberg, MD, FIDSA ; Larry M. Baddour, MD, FIDSA
    Impact of a Care Process Model on Management of Cardiovascular Implantable Electronic Device Infections
    Eugene Tan, MD ; Avish Nagpal, MD ; Daniel C. Desimone, MD ; Brenda Anderson, RN ; Jane Linderbaum, APRN, CNP ; Thomas De Ziel, RN ; Zhuo Li, MS ; Muhammad R. Sohail, MD, FIDSA ; Yong-Mei Cha, M.D. ; Erica Loomis, MD ; Raul Espinosa, MD ; Paul a. Friedman, MD ; Kevin Greason, MD ; Henry Schiller, MD ; Abinash Virk, MD, FIDSA ; Walter R. Wilson, MD, FIDSA ; James Steckelberg, MD, FIDSA ; Larry M. Baddour, MD, FIDSA
    Outcomes in Patients with Cardiovascular Implantable Electronic Device Infection Managed with Chronic Antibiotic Suppression
    Eugene M. Tan, MD ; Daniel C. Desimone, MD ; Muhammad R. Sohail, MD, FIDSA ; Larry M. Baddour, MD, FIDSA ; Walter R. Wilson, MD, FIDSA ; James M. Steckelberg, MD, FIDSA ; Abinash Virk, MD, FIDSA
    Therapy for Enterococcus faecalis Infective Endocarditis in the Era of A Dual Beta-Lactam Regimen: An Institutional Experience 2008-2015
    Abdelghani El Rafei, MD ; Daniel C. Desimone, MD ; Muhammad R. Sohail, MD, FIDSA ; James Steckelberg, MD, FIDSA ; Walter R. Wilson, MD, FIDSA ; Larry M. Baddour, MD, FIDSA
    Histological Findings in Infective Endocarditis
    Dylan Ely, BA ; Carmela D. Tan, MD ; E Rene Rodriguez, MD ; Syed Hussain, MD ; Gosta Pettersson, MD, PhD ; Steven Gordon, MD, FIDSA, FSHEA ; Nabin Shrestha, MD, MPH, FIDSA, FSHEA
    Posters
  • ie_histopath_poster.pdf (351.8 kB)
  • Distribution of Streptococcal Groups Causing Infective Endocarditis: A Descriptive Study
    So Lim Kim, BA ; Steven Gordon, MD, FIDSA, FSHEA ; Nabin Shrestha, MD, MPH, FIDSA, FSHEA
    Posters
  • Final IDSA Poster.pdf (88.3 kB)
  • Group C and G Streptococci: An Emerging Cause of Endocarditis and Severe Infections in Manitoba, Canada
    Sylvain Lother, MD ; Davinder Jassal, MD, FACC, FRCPC ; Philippe Lagacé-Wiens, MD, DTM&H, FRCPC ; Yoav Keynan, MD, PhD
    Comparing Sentinel Admission for Infective Endocarditis Among Patients With and Without Injection Drug Use: A Single Center Study
    P. Alexander Leahey, MD ; Mary Lasalvia, MD, MPH ; Elana Rosenthal, MD ; Adolf Karchmer, MD, FIDSA ; Christopher Rowley, MD/MPH
    Posters
  • Leahey - ID Week IE.pdf (447.0 kB)
  • Infectious Endocarditis and Morbidity: Epidemiological Patterns in the Setting of the Opioid Epidemic
    Kinna Thakarar, DO, MPH ; Kristina Rokas, PharmD, BCPS ; F.L. Lucas, PhD ; Elizabeth Andrews, MPH ; Christina Dematteo, DO ; Deirdre Mooney, MD, MPH ; Spencer Powers, MD ; Jeffrey Rosenblatt, MD ; August Valenti, MD ; Marcella Sorg, PhD ; Mylan Cohen, MD, MPH
    Posters
  • Endocarditis_poster_v4.pdf (390.3 kB)
  • Alcohol intake is a predictive factor of developing heart failure among patients with infective endocarditis.
    Fujiko Morita, MD ; Yuji Hirai, MD, PhD ; Kiyozumi Suzuki, MD ; Yuki Uehara, MD, PhD ; Kazunori Mitsuhashi, MD, PhD ; Toshio Naito, MD, PhD
    Posters
  • IDSA2016 alcohol IE HF.pdf (649.0 kB)
  • Outpatient Treatment of Infective Endocarditis (IE) at Physician Office Infusion Centers (POICs): A 2-Year Analysis of Clinical and Economic Outcomes
    Brian S. Metzger, MD, MPH ; Richard M. Mandel, MD, FIDSA ; Jorge R. Bernett, MD ; Barry Statner, MD, FRCPC, FIDSA ; John S. Adams, MD, FIDSA, FSHEA ; Alfred E. Bacon, III, MD ; Kimberly Couch, PharmD, MA, FIDSA, FASHP ; Claudia P. Schroeder, PharmD, PhD ; Lucinda J. Van Anglen, PharmD
    Impact of an Endocarditis Team in the management of 357 Infective Endocarditis
    Nahema Issa, MD ; Marina Dijos, MD ; Carine Greib, MD ; Gaetane Wirth, MD ; Olivia Peuchant, MD, PhD ; Marion Laine, MD ; Laurent Barandon, MDPhD ; Fabrice Camou, MD
    Posters
  • POSTER EI IDWEEK 2016.pdf (582.2 kB)
  • Bacillus species bloodstream infections among pediatric oncology patients: When is line removal really necessary?
    Sonia Mehra, MD ; Adam L. Hersh, MD, PhD ; Anne J. Blaschke, MD, PhD, FIDSA, FPIDS ; Chris Stockmann, PhD, MSc ; Richard Lemons, MD ; Joshua Schiffman, MD ; E. Kent Korgenski, MS ; Andrew Pavia, MD, FIDSA, FSHEA, FPIDS ; Elizabeth Knackstedt, MD
    Posters
  • IDSA bacillus 10-21-16 .pdf (1.0 MB)
  • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.